Cognitive performance and estrogen use in nondemented older women

Journal of the American Geriatrics Society

Volumn 47, Issue 10, 1999, Pages 1267-1268

  Newman, Anne B ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ESTROGEN;

CLINICAL TRIAL; COGNITION; DEMENTIA; EDITORIAL; ESTROGEN THERAPY; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; NONHUMAN; POSTMENOPAUSE; PREVALENCE;

EID: 0032822625     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb05213.x     Document Type: Editorial

References (17)

1. Steffens DC, Norton MC, Plassman BL, et al., Enhanced cognitive performance with estrogen use in non-demented community dwelling older women. J Am Geriatr Soc 1999; 47: 000-000.
2. Shumaker SA, Reboussin BA, Espeland MA, et al., The Women's Health Initiative Memory Study: A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998; 19: 604-621.
3. Tang MX, Jacobs D., Stern Y., et al., Effect of oestrogen during menopause and age at onset of Alzheimer's disease. Lancet 1996; 348: 429-432.
4. Kawas C., Resnick S., Morrison A., et al., A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal study on Aging. Neurology 1997; 48: 1517-1521.
5. Paganini-Hill A., Henderson VW,. Estrogen deficiency and risk of Alzheimer's s disease in women. Am J Epidemiol 1994; 140: 256-261.
6. Yaffe K., Sawaya G., Lieberburg I., Grady D.,. Estrogen therapy in postmenopausal A -women: Effects on cognitive function and dementia. JAMA 1998; 279: 688-695.
7. Barrett-Connor E., Kritz-Silverstein D.,. Estrogen replacement and cognitive function in older women. JAMA 1993; 269: 2637-2641.
8. Matthews K., Cauley JA, Yaffe K., Zmuda JM,. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 1999; 47: 518-523.
9. Belle SH, Seaberg EC, Ganguli M., et al., Effect of education and gender adjustment on the sensitivity and specificity of a cognitive screening battery for dementia: Results from the MOVIES Project. Neuroepidemiology 1996; 15: 321-329.
10. Pearlstein T., Rosen K., Stone AB,. Mood disorders and the menopause. Endocrinol Metab Clin North Am 1997; 26: 279-294.
11. Srivastava RA, Bhasin N., Srivastava N.,. Apolipoprotein E gene expression in the various tissues in the mouse and regulation by estrogen. Biochem Mol Biollnt 1996; 38: 91-101.
12. Yaffe K., Cauley J., Sands L., Browner W.,. Apolipoprotein F. phenotype and cognitive decline in a prospective study of elderly community women. Arch Neurol 1997; 54: 1110-1114.
13. Grodstein F., Stampfer MJ, Colditz GA, et al., Postmenopausal replacement therapy and mortality. N Engl J Med 1997; 336: 1769-1775.
14. Grodstein F., Stampfer MJ, Manson JE, et al., Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453-461.
15. Jonas HA, Kronmal RA, Psaty BM, et al., Current estrogen-progestin and estrogen replacement therapy in elderly women: Association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study. Ann Epidemiol 1996; 6: 314-323.
16. Cauley JA, Seeley DG, Ensrud K., et al., Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995; 122: 9-16.
17. Petitti DB,. Hormone replacement therapy and heart disease prevention: Experimentation trumps observation. JAMA 1998; 280: 650-652.